Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells |
| |
Authors: | Ellingsgaard Helga Hauselmann Irina Schuler Beat Habib Abdella M Baggio Laurie L Meier Daniel T Eppler Elisabeth Bouzakri Karim Wueest Stephan Muller Yannick D Hansen Ann Maria Kruse Reinecke Manfred Konrad Daniel Gassmann Max Reimann Frank Halban Philippe A Gromada Jesper Drucker Daniel J Gribble Fiona M Ehses Jan A Donath Marc Y |
| |
Affiliation: | Clinic for Endocrinology, Diabetes & Metabolism and Department Biomedicine, University Hospital Basel, Basel, Switzerland. helga.ellingsgaard@unibas.ch |
| |
Abstract: | Exercise, obesity and type 2 diabetes are associated with elevated plasma concentrations of interleukin-6 (IL-6). Glucagon-like peptide-1 (GLP-1) is a hormone that induces insulin secretion. Here we show that administration of IL-6 or elevated IL-6 concentrations in response to exercise stimulate GLP-1 secretion from intestinal L cells and pancreatic alpha cells, improving insulin secretion and glycemia. IL-6 increased GLP-1 production from alpha cells through increased proglucagon (which is encoded by GCG) and prohormone convertase 1/3 expression. In models of type 2 diabetes, the beneficial effects of IL-6 were maintained, and IL-6 neutralization resulted in further elevation of glycemia and reduced pancreatic GLP-1. Hence, IL-6 mediates crosstalk between insulin-sensitive tissues, intestinal L cells and pancreatic islets to adapt to changes in insulin demand. This previously unidentified endocrine loop implicates IL-6 in the regulation of insulin secretion and suggests that drugs modulating this loop may be useful in type 2 diabetes. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|